نتایج جستجو برای: xpert mtbrif assay

تعداد نتایج: 222590  

Journal: :The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2015
M Singh G R Sethi M Mantan A Khanna M Hanif

SETTING A tertiary care teaching hospital in New Delhi, India. OBJECTIVE To determine the sensitivity and specificity of the Xpert(®) MTB/RIF assay in paediatric pulmonary tuberculosis (PTB) using MGIT™ culture as gold standard. METHODS After ethical approval had been obtained, 50 patients aged 0-14 years with suspected PTB were enrolled. Sputum/induced sputum and gastric lavage from the pa...

2016
A. Jayakumar R. M. Savic C. K. Everett D. Benator D. Alland C. M. Heilig M. Weiner S. O. Friedrich N. A. Martinson A. Kerrigan C. Zamudio S. V. Goldberg W. C. Whitworth J. L. Davis P. Nahid

The Xpert MTB/RIF assay is both sensitive and specific as a diagnostic test. Xpert also reports quantitative output in cycle threshold (CT) values, which may provide a dynamic measure of sputum bacillary burden when used longitudinally. We evaluated the relationship between Xpert CT trajectory and drug exposure during tuberculosis (TB) treatment to assess the potential utility of Xpert CT for t...

Journal: :The new microbiologica 2017
Andrea Sambri Giovanni Pignatti Matteo Romagnoli Davide Donati Maurilio Marcacci Matteo Cadossi

The aim of this prospective study was to evaluate the performance of the Polymerase Chain Reaction (PCR) tool Xpert MRSA/SA SSTI test (Cepheid, Sunnyvale, CA, USA) on periprosthetic samples from a cohort of patients with suspected prosthetic joint infection (PJI). Seventy adult patients were included in this prospective study. On the basis of the preoperative evaluation, 39 patients were clinic...

2013
Maunank Shah Violet Chihota Gerrit Coetzee Gavin Churchyard Susan E Dorman

BACKGROUND The World Health Organization has endorsed the use of molecular methods for the detection of TB and drug-resistant TB as a rapid alternative to culture-based systems. In South Africa, the Xpert MTB/Rif assay and the GenoType MTBDRplus have been implemented into reference laboratories for diagnosis of TB and drug-resistance, but their costs have not been fully elucidated. METHODS We...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015
Lelia H Chaisson J Lucian Davis

TO THE EDITOR—We thank Drs Baker and Holtom [1] for their thoughtful comments on the low number of smear-negative, culture-positive tuberculosis cases in our study [2] and another recent study [3] of the GeneXpert MTB/RIF assay (Xpert). They astutely point out that this may have led us to underestimate the potential benefit of Xpert in low-burden settings. We agree that the incremental sensitiv...

Journal: :Journal of acquired immune deficiency syndromes 2012
Stephen D Lawn Andrew D Kerkhoff Monica Vogt Robin Wood

We determined the diagnostic yield of the Xpert MTB/RIF assay for tuberculosis (TB) when testing small volumes of urine from ambulatory HIV-infected patients before starting antiretroviral therapy in South Africa. Compared with a gold standard of sputum culture, the sensitivity of urine Xpert among those with CD4 cell counts of <50, 50-100, and >100 cells per microliter were 44.4%, 25.0%, and 2...

Journal: :The Lancet. Respiratory medicine 2013
Sven O Friedrich Andrea Rachow Elmar Saathoff Kasha Singh Chacha D Mangu Rodney Dawson Patrick Pj Phillips Amour Venter Anna Bateson Catharina C Boehme Norbert Heinrich Robert D Hunt Martin J Boeree Alimuddin Zumla Timothy D McHugh Stephen H Gillespie Andreas H Diacon Michael Hoelscher

BACKGROUND An accurate biomarker is urgently needed to monitor the response to treatment in patients with pulmonary tuberculosis. The Xpert MTB/RIF assay is a commercially available real-time PCR that can be used to detect Mycobacterium-tuberculosis-specific DNA sequences in sputum samples. We therefore evaluated this assay with serial sputum samples obtained over 26 weeks from patients undergo...

2017
Kirsten Kost Jumi Yi Beverly Rogers Robert Jerris

We evaluated detection of carbapenem-resistant Enterobacteriaceae (CRE) by routine minimal inhibitory concentration (MIC) testing, polymerase chain reaction (PCR) using Xpert® Carba-R assay, hydrolysis of ertapenem and imipenem detected by matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS), and hydrolysis by colorimetry using the EPI-CRE assay. Ninety-si...

2017
Tarsizio Chikaonda Nelson Nguluwe Brian Barnett Runa H Gokhale Robert Krysiak Isaac Thengolose Nora E Rosenberg Christopher Stanley James Mpunga Irving F Hoffman Mina Hosseinipour Lesley Scott Wendy Stevens

BACKGROUND Xpert® MTB/RIF is a molecular test for the detection of Mycobacterium tuberculosis and rifampicin resistance. It is considered to be a great advance over smear microscopy and culture. However, there is very little information regarding the performance characteristics of Xpert MTB/RIF in Malawi. OBJECTIVE We aimed to evaluate the performance of Xpert MTB/RIF in a Malawian setting. ...

Journal: :The Lancet. Infectious diseases 2013
Stephen D Lawn Peter Mwaba Matthew Bates Amy Piatek Heather Alexander Ben J Marais Luis E Cuevas Timothy D McHugh Lynn Zijenah Nathan Kapata Ibrahim Abubakar Ruth McNerney Michael Hoelscher Ziad A Memish Giovanni Battista Migliori Peter Kim Markus Maeurer Marco Schito Alimuddin Zumla

Rapid progress has been made in the development of new diagnostic assays for tuberculosis in recent years. New technologies have been developed and assessed, and are now being implemented. The Xpert MTB/RIF assay, which enables simultaneous detection of Mycobacterium tuberculosis (MTB) and rifampicin (RIF) resistance, was endorsed by WHO in December, 2010. This assay was specifically recommende...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید